{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:35:35Z","timestamp":1781199335750,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1998,5,1]],"date-time":"1998-05-01T00:00:00Z","timestamp":893980800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[1998,5]]},"DOI":"10.1038\/eye.1998.83","type":"journal-article","created":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T08:59:42Z","timestamp":1309769982000},"page":"343-349","source":"Crossref","is-referenced-by-count":43,"title":["Sclerosing canaliculitis after 5-fluorouracil breast cancer chemotherapy"],"prefix":"10.1038","volume":"12","author":[{"given":"Vickie","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M","family":"Olver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFeye199883_CR1","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/1097-0142(196811)22:6<1233::AID-CNCR2820220621>3.0.CO;2-N","volume":"22","author":"EM Jacobs","year":"1968","unstructured":"Jacobs EM, Luce JK, Wood DA . Treatment of cancer with weekly intravenous 5-fluorouracil. Cancer 1968;22:1233\u20138.","journal-title":"Cancer"},{"key":"BFeye199883_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1001\/archopht.1981.03930010286013","volume":"99","author":"LP Caravella","year":"1981","unstructured":"Caravella LP, Burns JA, Zangmeister M . Punctal-canalicular stenosis related to systemic fluorouracil therapy. Arch Ophthalmol 1981;99:284\u20136.","journal-title":"Arch Ophthalmol"},{"key":"BFeye199883_CR3","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1002\/1097-0142(19851015)56:8<2148::AID-CNCR2820560845>3.0.CO;2-R","volume":"56","author":"SR Seiff","year":"1985","unstructured":"Seiff SR, Shorr N, Adams T . Surgical treatment of punctal-canalicular fibrosis from 5-fluorouracil therapy. Cancer 1985;56:2148\u20139.","journal-title":"Cancer"},{"key":"BFeye199883_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01203288","volume":"90","author":"HMA Brink","year":"1995","unstructured":"Brink HMA, Beex LVAM . Punctal and canalicular stenosis associated with systemic fluorouracil therapy. Doc Ophthalmol 1995;90:1\u20136.","journal-title":"Doc Ophthalmol"},{"key":"BFeye199883_CR5","first-page":"1","volume":"33","author":"E Greenspan","year":"1972","unstructured":"Greenspan E . Combination cytotoxic chemotherapy in advanced disseminated breast cancer. J Mt Sinai Hosp 1972;33:1\u201327.","journal-title":"J Mt Sinai Hosp"},{"key":"BFeye199883_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/1097-0142(197907)44:1<69::AID-CNCR2820440113>3.0.CO;2-O","volume":"44","author":"G Kende","year":"1979","unstructured":"Kende G, Sirki SR, Thomas PRM, et al. Blurring of vision: a previously undescribed complication of cyclophosphamide therapy. Cancer 1979;44:69\u201371.","journal-title":"Cancer"},{"key":"BFeye199883_CR7","first-page":"709","volume":"13","author":"MK Jack","year":"1981","unstructured":"Jack MK, Hicks JD . Ocular complications in high dose chemoradiotherapy and marrow transplantation. Ann Ophthalmol 1981;13:709\u201311.","journal-title":"Ann Ophthalmol"},{"key":"BFeye199883_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0161-6420(83)34600-5","volume":"90","author":"FT Fraunfelder","year":"1983","unstructured":"Fraunfelder FT, Meyers SM . Ocular toxicity of antineoplastic agents. Ophthalmology 1983;90:1\u20133.","journal-title":"Ophthalmology"},{"key":"BFeye199883_CR9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/0039-6257(89)90105-7","volume":"34","author":"PS Imperia","year":"1989","unstructured":"Imperia PS, Lazarus HM, Lass JH . Ocular complications of systemic cancer therapy. Surv Ophthalmol 1989;34:220\u201330.","journal-title":"Surv Ophthalmol"},{"key":"BFeye199883_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1056\/NEJM197602192940801","volume":"294","author":"G Bonadonna","year":"1976","unstructured":"Bonadonna G, Brusamolino E, Pinuccia V, Rossi A, Brugnatelli L, Brambilla C, et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 1976;294:405\u201310.","journal-title":"N Engl J Med"},{"key":"BFeye199883_CR11","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/1097-0142(19811115)48:10<2158::AID-CNCR2820481007>3.0.CO;2-I","volume":"48","author":"JH Doroshow","year":"1981","unstructured":"Doroshow JH, Locker GY, Gasterland DE, et al. Ocular irritation from high dose methotrexate therapy: pharmacokinetics of drug in the tear film. Cancer 1981;48:2158\u201362.","journal-title":"Cancer"},{"key":"BFeye199883_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0002-9394(83)90453-1","volume":"96","author":"WH Stern","year":"1983","unstructured":"Stern WH, Guerin CJ, Erickson PA, Lewis GP, Anderson DH, Fisher SK . Ocular toxicity of fluorouracil after vitrectomy. Am J Ophthalmol 1983;96:43\u201351.","journal-title":"Am J Ophthalmol"},{"key":"BFeye199883_CR13","first-page":"580","volume":"26","author":"MS Shapiro","year":"1985","unstructured":"Shapiro MS, Thoft RA, Friend J, Parrish RK, Gressel MG . 5-Fluorouracil toxicity to the ocular surface epithelium. Invest Ophthalmol Vis Sci 1985;26:580\u20133.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye199883_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/mpo.2950030104","volume":"3","author":"DJ Straus","year":"1977","unstructured":"Straus DJ, Mausolf FA, Ellerby RA, McCracken JD . Cicatricial ectropion secondary to 5-fluorouracil therapy. Med Pediatr Oncol 1977;3:15\u20139.","journal-title":"Med Pediatr Oncol"},{"key":"BFeye199883_CR15","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/jama.1973.03220340051021","volume":"225","author":"J Hammersley","year":"1973","unstructured":"Hammersley J, Luce JK, Florent TR, Burkholder MM . Excessive lacrimation from fluorouracil treatment. JAMA 1973;225:747\u20138.","journal-title":"JAMA"},{"key":"BFeye199883_CR16","first-page":"56","volume":"23","author":"N Christophidis","year":"1977","unstructured":"Christophidis N, Vajda FJE, Lucas I, Drummer O, Moon WJ, Louis WJ . Excessive lacrimation associated with detectable concentrations of 5FU in tears and plasma. Proc Aust Soc Clin Exp Pharmacol 1977;23:56.","journal-title":"Proc Aust Soc Clin Exp Pharmacol"},{"key":"BFeye199883_CR17","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1200\/JCO.1987.5.10.1523","volume":"5","author":"J Aisner","year":"1987","unstructured":"Aisner J, Weinberg V, Perloff R, Weiss M, Korzun A, et al. Chemotherapy versus chemoimmunotherapy (CAF v CAFP v CMF Each \u00b1 MER) for metastatic carcinoma of the breast: a CALGB study. J Clin Oncol 1987: 5;1523\u201333.","journal-title":"J Clin Oncol"},{"key":"BFeye199883_CR18","doi-asserted-by":"crossref","unstructured":"Jones LT . Epiphora. II. Its relation to the anatomical structures and surgery of the medial canthal region. Am J Ophthalmol 1957;43:203\u201312.","DOI":"10.1016\/0002-9394(57)92911-2"},{"key":"BFeye199883_CR19","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0161-6420(92)31839-1","volume":"99","author":"BB Becker","year":"1992","unstructured":"Becker BB . Tricompartmental model of the lacrimal pump mechanism. Ophthalmology 1992;99:1139\u201345.","journal-title":"Ophthalmology"},{"key":"BFeye199883_CR20","unstructured":"Hurwitz JJ . Canalicular diseases. In: Hurtwitz JJ, editor. The lacrimal system. New York: Lippincott-Raven, 1996:139\u201347."},{"key":"BFeye199883_CR21","first-page":"165","volume":"3","author":"ER Veirs","year":"1984","unstructured":"Veirs ER, Brindley GO . Management of canalicular obstruction. Adv Ophthalmic Plast Reconstruct Surg 1984;3:165\u20139.","journal-title":"Adv Ophthalmic Plast Reconstruct Surg"},{"key":"BFeye199883_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1159\/000305933","volume":"159","author":"R Barishak","year":"1969","unstructured":"Barishak R, Romano A, Stein R . Obstruction of lacrimal sac caused by topical epinephrine. Ophthalmologica 1969;159:373\u20139.","journal-title":"Ophthalmologica"},{"key":"BFeye199883_CR23","first-page":"351","volume":"23","author":"R Silkiss","year":"1992","unstructured":"Silkiss R, Axelrod RN, Iwach AG, Vassiliadis A, Hennings DR . Transcanalicular THGYAG dacryocystorhinostomy. Ophthalmic Surg 1992;23:351\u20133.","journal-title":"Ophthalmic Surg"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye199883.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye199883","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye199883.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:41:35Z","timestamp":1684431695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye199883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,5]]}},"alternative-id":["BFeye199883"],"URL":"https:\/\/doi.org\/10.1038\/eye.1998.83","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,5]]}}}